OpenFilings

REGENERON PHARMACEUTICALS, INC.

Form10-K

Report Period2021-12-31

Date Filed2022-02-07

Time Filed09:25:49

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
FOURTH AMENDMENT TO LICENSE AND COLLAB AGREEMENT - SANOFI
AMENDMENT 01 TO CREDIT AGREEMENT - JPMORGAN CHASE BANK NA AND LENDERS
FIRST AMENDMENT TO IO LICENSE AND COLLAB AGREEMENT - SANOFI
FIRST AMENDMENT TO PARTICIPATION AGREEMENT
SUBSIDIARIES OF THE REGISTRANT
CONSENT OF PRICEWATERHOUSECOOPERS LLP
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
Filing on SEC Edgar